
Left ventricular global longitudinal strain (LVGLS) has improved risk stratification in patients with LV systolic dysfunction and subsequent recovery of LV ejection fraction (LVEF) in the acquired heart disease population. This study aimed to assess the relationship between LVGLS and cardiovascular events (heart failure hospitalization, sustained ventricular tachycardia/appropriate shock, heart transplant, or cardiovascular death) and deterioration in LVEF in adults with congenital heart disease. The study demonstrated that LVGLS could identify patients at risk for adverse outcomes. Medical therapy for heart failure and the treatment of hypertension may reduce the risk of adverse effects, but these findings require empirical validation, hence the need for a clinical trial.
Like
Save
Share